Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
71.36
+0.45 (0.63%)
Sep 1, 2026, 10:54 AM EDT - Market open

Cytokinetics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-894-784.96-589.53-526.24-388.96-215.31
Depreciation & Amortization
12.5510.139.5311.895.812.28
Loss (Gain) From Sale of Assets
--0.05---
Asset Writedown & Restructuring Costs
-----2.84
Loss (Gain) From Sale of Investments
-0.13-0.03-0.020.040.11-
Stock-Based Compensation
127.31112.2997.8472.0747.8526.83
Other Operating Activities
203.6188.1950.5824.8360.3732.38
Change in Accounts Receivable
-16.02-1.11-15.37-1.1456.67-47.4
Change in Accounts Payable
7.842.66-4.48-3.484.521.06
Change in Unearned Revenue
0.31-50.7652.37--87-
Change in Other Net Operating Assets
8.9213.583.147.711.154.8
Operating Cash Flow
-555.45-510.01-395.89-414.33-299.52-142.52
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-25.26-24.81-3.91-1.42-11.34-48.87
Investment in Securities
-478.4241.47-549.19240.67-250.8-98.91
Investing Cash Flow
-503.6816.67-553.1239.25-262.13-147.78

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-729.46--523.59-
Long-Term Debt Repaid
--413.51-9.62-0.86-188.93-
Net Debt Issued (Repaid)
314.99315.95-9.62-0.86334.66-
Issuance of Common Stock
831.0835.98759.86182.6917.54324.85
Repurchase of Common Stock
-4.27-2.47-19.63-10.52-9.6-4.87
Other Financing Activities
10017520050173.56-
Financing Cash Flow
1,242524.46930.61221.32516.17319.98

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.84-0.720.21-0.02--
Net Cash Flow
181.8330.4-18.1746.22-45.4829.68

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-580.72-534.82-399.8-415.75-310.85-191.39
Free Cash Flow Growth
------
Free Cash Flow Margin
-858.16%-607.48%-2164.10%-5521.23%-328.64%-271.76%
Free Cash Flow Per Share
-4.67-4.45-3.57-4.31-3.46-2.49
Levered Free Cash Flow
-397.41-379.62-241.29-260.37-127.01-179.83
Unlevered Free Cash Flow
-319.39-314.7-187.22-224.33-95.04-161.5

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
24.8622.9125.9710.315.179.18
Change in Working Capital
-4.77-35.6335.663.09-24.78.46
SEC Filings: 10-K · 10-Q